Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition.

Autor: Cavina, Lorenzo1 (AUTHOR) boumamathijs@gmail.com, Bouma, Mathijs J.1 (AUTHOR) daniel@girones-pbcs.com, Gironés, Daniel1,2 (AUTHOR), Feiters, Martin C.1 (AUTHOR) l.cavina@science.ru.nl
Zdroj: Molecules. Sep2024, Vol. 29 Issue 17, p4047. 27p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje